MOLECULAR-REARRANGEMENTS OF THE TAL-1/SCL GENE IN HUMAN ACUTE LYMPHOBLASTIC LEUKEMIAS

被引:0
|
作者
LARSEN, CJ [1 ]
BERNARD, O [1 ]
MATHIEUMAHUL, D [1 ]
机构
[1] USLT2,CNRS,INST GENET & BIOL CELLULAIRE,F-34000 MONTPELLIER,FRANCE
来源
BULLETIN DE L INSTITUT PASTEUR | 1993年 / 91卷 / 01期
关键词
LEUKEMIA; T-LYMPHOCYTE; THYMUS; TAL-1; GENE; IMMUNOGENETICS; TRANSLOCATION; DELETIONS; TRANSCRIPTS; LEUKEMOGENESIS; HUMAN; ALL; LYMPHOPROLIFERATIVE MALIGNANCIES; REVIEW;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A majority of recurrent chromosome abnormalities found in human acute lymphoproliferative malignancies implicate genes whose products are involved in the control of proliferation/differentiation processes. One member of this category is the tal-1/SCL gene, which encodes a protein with a basic helix-loop-helix motif; tal-1 was first identified by molecular analysis of a t(1;14) translocation in a T-cell acute leukaemia (T-ALL). While this chromosome abnormality is rare, chromosome 1 interstitial deletions that impair the 5' end of tal-1 are present much more frequently in T-ALL. The fact that tal-1 alterations are strongly associated with T-ALL argues in favor of a role for the impaired tal-1 gene in the leukaemogenic process in this human leukaemia.
引用
收藏
页码:17 / 29
页数:13
相关论文
共 50 条
  • [21] Chromatin immunoselection defines a TAL-1 target gene
    Cohen-Kaminsky, S
    Maouche-Chrétien, L
    Vitelli, L
    Vinit, MA
    Blanchard, I
    Yamamoto, M
    Peschle, C
    Roméo, PH
    EMBO JOURNAL, 1998, 17 (17): : 5151 - 5160
  • [22] NF-κB activation in premalignant mouse tal-1/scl thymocytes and tumors
    O'Neil, J
    Ventura, JJ
    Cusson, N
    Kelliher, M
    BLOOD, 2003, 102 (07) : 2593 - 2596
  • [23] Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis
    Kassouf, Mira T.
    Chagraoui, Hedia
    Vyas, Paresh
    Porcher, Catherine
    BLOOD, 2008, 112 (04) : 1056 - 1067
  • [24] 2 SITE-SPECIFIC DELETIONS AND T(1,14) TRANSLOCATION RESTRICTED TO HUMAN T-CELL ACUTE LEUKEMIAS DISRUPT THE 5' PART OF THE TAL-1 GENE
    BERNARD, O
    LECOINTE, N
    JONVEAUX, P
    SOUYRI, M
    MAUCHAUFFE, M
    BERGER, R
    LARSEN, CJ
    MATHIEUMAHUL, D
    ONCOGENE, 1991, 6 (08) : 1477 - 1488
  • [25] Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase II alpha
    Kelliher, MA
    Seldin, DC
    Leder, P
    EMBO JOURNAL, 1996, 15 (19): : 5160 - 5166
  • [26] SCL/Tal-1 activates erythropoietin receptor expression and induces a mature erythroid phenotype.
    Yu, XB
    Brandt, SJ
    Noguchi, CT
    BLOOD, 2000, 96 (11) : 285A - 285A
  • [27] The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages
    Porcher, C
    Swat, W
    Rockwell, K
    Fujiwara, Y
    Alt, FW
    Orkin, SH
    CELL, 1996, 86 (01) : 47 - 57
  • [28] GENE FUSION AND REARRANGEMENTS IN HUMAN LEUKEMIAS
    RABBITTS, TH
    BAER, R
    MENGLEGAW, L
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1986, 367 (04): : 261 - 262
  • [29] Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and TAL-1 (SCL)
    Lowsky, R
    DeCoteau, JF
    Reitmair, AH
    Ichinohasama, R
    Dong, WF
    Xu, Y
    Mak, TW
    Kadin, ME
    Minden, MD
    BLOOD, 1997, 89 (07) : 2276 - 2282
  • [30] Complete block to hematopoiesis in the absence of the T-cell leukemia oncoprotein SCL/TAL-1
    Porcher, C
    Swat, W
    Rockwell, K
    Fujiwara, Y
    Shivdasani, R
    Alt, F
    Orkin, SH
    BLOOD, 1995, 86 (10) : 999 - 999